Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans.

NCT ID: NCT04698889

Last Updated: 2021-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-07

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Human milk, despite a much lower protein content, is as effective as cow milk on insulin stimulation under iso-lactose conditions. The causes for such a similar potency are unknown. This effect could be due to incretin and amino-acid responses, and/or to milk-protein interactions.In this study the investigators will address the above question(s) by testing, in young healthy volunteers, the effects of natural cow and human milk, as well as of the manipulation of the casein and whey protein content in cow milk, on insulin, C-peptide, GLP-1 and GIP secretion, as well as on circulating amino acids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: To determine plasma glucose, insulin, C-peptide, glucagon-like polypeptide-1 (GLP-1), glucose-inhibitory-polypeptide (GIP) and amino-acid responses, following administration of human and cow milk, either natural or with experimentally-modified casein and whey-protein content(s).

Design. Young healthy volunteers of both sexes will receive iso-lactose loads (0.36 g lactose / kg body weight) of: natural cow milk; natural human milk; and of cow milk with modified casein and whey protein contents. Blood samples will be frequently collected over 4 hours. Plasma glucose, amino acids, insulin and incretin concentrations will be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insulin Tolerance Hormone Aminoacidaemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Subjects allocated to receive one or more milk types in random order on different occasions, spaced by at least two weeks
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cow milk

Administration of natural cow whole milk

Group Type ACTIVE_COMPARATOR

natural cow

Intervention Type DIETARY_SUPPLEMENT

Human milk

Administration of natural human milk

Group Type ACTIVE_COMPARATOR

natural human

Intervention Type DIETARY_SUPPLEMENT

Modified cow milk - low protein

Administration of modified cow milk at low protein content

Group Type ACTIVE_COMPARATOR

low protein cow milk

Intervention Type DIETARY_SUPPLEMENT

Modified cow milk - high protein

Administration of modified cow milk at high protein content

Group Type ACTIVE_COMPARATOR

high protein cow milk

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

natural cow

Intervention Type DIETARY_SUPPLEMENT

high protein cow milk

Intervention Type DIETARY_SUPPLEMENT

natural human

Intervention Type DIETARY_SUPPLEMENT

low protein cow milk

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 20-35 yrs
* Both sexes
* Healthy
* In post-absorptive state
* Hemoglobin Hb1c values within normal values.
* Previous regular, moderate physical activity
* Stable body weight and regular dietary habits.

Exclusion Criteria

* Familial or personal history of diabetes.
* Altered fasting glucose and/ or impaired glucose tolerance.
* Any metabolic, hormonal, hepatic, renal, and cardiovascular disease.
* Current drug treatments
Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Padova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tessari Paolo

Professor, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Document Type: Study Protocol

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Tessari Protocol 1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.